NCT06965010

Measurement Based Care in Opioid Treatment Programs

Enrolling by Invitation
NAAges 18+InterventionalTreatment
University of Pittsburgh
~3,650 participants
Updated 2025-11-10 on ClinicalTrials.gov
What's tested:Measurement-based careMeasurement As Usual

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Patient Treatment Retention - Clinical Effectiveness Outcome
Measured over Continuous following new MOUD patient intake events during the 9-month periods prior to and during MBC+/Implementation Phase in an OTP
+6 more outcomes measured
Opioid Use Disorder
1 sites across 1 states
Pennsylvania1
  • Renee Cloutier, PhD · PRINCIPAL_INVESTIGATOR · University of Pittsburgh
  • Kelli S Scott, PhD · PRINCIPAL_INVESTIGATOR · Northwestern University
  • Arnie Aldridge, PhD · PRINCIPAL_INVESTIGATOR · RTI International

This trial hasn't published a contact. View it on ClinicalTrials.gov

  • Change in Patient Treatment Retention - Clinical Effectiveness OutcomeContinuous following new MOUD patient intake events during the 9-month periods prior to and during MBC+/Implementation Phase in an OTP

    Change in Patient Treatment Retention: clinic-level outcome measure that tracks the duration of OUD treatment based on medications, counseling and related services, as recorded in the claims data. Specific measures are the (1) % of patients still in treatment 6 months after initiating MOUD and (2) the average number of months new MOUD patients remain in treatment (12-month follow-up window).

  • Change in Patient's Perceived Recovery - Clinical Effectiveness OutcomeMonthly during the 9-month MBC+/Implementation Phase, sub-group of OTP sites during 9-month period pre-MBC+/Implementation Phase

    Change in Patient Recovery: patient-level outcome measure that evaluates progress in patient recovery obtained from survey data. The Brief Addiction Monitoring assessment question will be administered monthly to monitor substance use.

  • Change in Patient Quality of Life - Clinical Effectiveness OutcomeAt baseline and every 3 months during the 9-month MBC+/Implementation Phase, sub-group of OTP sites during 9-month period pre-MBC+/Implementation Phase

    Change in Patient Quality of Life: patient-level outcome measure that evaluates progress in patient quality of life. The Patient-Reported Outcomes Measurement Information System (PROMIS-29) Instrument will be administered at baseline and at every 3 months to evaluate and monitor physical, mental, and social health via The Greenspace Mental Health tool.

  • Sustainment of Measurement-Based Care ImplementationDuring the Sustainment Phase ~9 months post-Implementation

    The sustainment of MBC implementation is defined as the extent to which providers continue to use MBC tools with fidelity following the removal of active implementation support, based on data sourced from Greenspace and/or provider surveys. Each treatment session will continue to receive a score of "1" for documentation of MBC data collection, a "2" for documented data sharing, and a "3" for documented action informed by data. Sessions without MBC documentation will receive a "0." Sustainability is assessed by examining whether fidelity to core MBC components is maintained over time. Potential metrics include: Percentage of sessions with completed MBC assessments during Sustainment Percentage of sessions where MBC results were reviewed with patients during Sustainment Percentage of sessions with documented action taken during Sustainment Percentage of providers meeting a predefined threshold for sustained fidelity (e.g., 80% of sessions scoring ≥2) during Sustainment

  • Fidelity of Measurement-Based Care ImplementationMonthly during the 9-month MBC+/Implementation Phase

    The Fidelity of MBC Implementation is defined as the extent to which providers administer and use MBC tools as intended based on data sourced from Greenspace and/or provider surveys during the Implementation Phase. MBC fidelity will be a single outcome measure that ranges from 0-3. Each treatment session will receive a "1" for documentation of MBC data collection, a "2" for documented data sharing, and a "3" for documented action informed by data. All attended appointments without MBC documentation will receive a "0." Potential metrics include: Percentage of sessions with completed MBC assessments Percentage of sessions where MBC results were reviewed with patients Percentage of sessions with documented action taken

  • Adoption of Measurement-Based Care Implementation as Assessed by Patient Surveys - Measure Implementation OutcomeMonthly during the 9-month MBC+/Implementation Phase

    The adoption of MBC implementation will be assessed based on the percentage of OTP treatment providers who use MBC during and after active implementation. Adoption will be measured using patient surveys during the Implementation Phase.

  • Adoption of Measurement-Based Care Implementation as Assessed by Greenspace Mental Health tools - Measure Implementation OutcomeMonthly during the 9-month MBC+/Implementation Phase

    The adoption of MBC implementation will be assessed based on the percentage of OTP treatment providers who use MBC during and after active implementation. Adoption will be measured using Greenspace Mental Health tools during the Implementation Phase.